Physician profile
Joseph D Funk
NPI 1023089869
$7,156.85
in general payments reported to CMS, 2019-2025
13 companies · $61.25 in 2025
The $61.25 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $3,542 · 2021: $100 · 2022: $2,569 · 2023: $207 · 2024: $240 · 2025: $61.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,579.22 | 2020-2024 | |
| Reel Surgical, INC. | $2,478.58 | 2022-2023 | |
| Stryker Corporation | $452.12 | 2019-2024 | Ortholoc 3di, Inbone, Variax |
| Linvatec Corporation | $153.60 | 2023 | Biobrace 23mm |
| Crossroads Extremity Systems, LLC | $145.81 | 2020 | |
| Paratek Pharmaceuticals, INC. | $108.77 | 2022 | |
| Organogenesis INC. | $100.00 | 2021 | |
| Amgen INC. | $61.25 | 2025 | Krystexxa |
| Wright Medical Technology, INC. | $29.85 | 2019 | |
| Kerecis Limited | $14.76 | 2022 | |
| Heron Therapeutics, INC. | $12.89 | 2022 | |
| Portola Pharmaceuticals, LLC | $12.78 | 2019 | |
| Ossio INC | $7.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Funk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.